Results 21 to 30 of about 8,448,017 (179)

Impact of orphan drugs on Latvian budget [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2016
Number of orphan medicinal products on the market and number of rare disease patients, taking these usually expensive products, are increasing. As a result, budget impact of orphan drugs is growing. This factor, along with the cost-effectiveness of orphan drugs, is often considered in the reimbursement decisions, directly affecting accessibility of ...
Logviss, Konstantins   +2 more
openaire   +2 more sources

Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure and Iron Deficiency in Romania

open access: yesJournal of Cardiovascular Emergencies, 2019
Background: Ferric carboxymaltose (FCM) treatment in case of iron deficient (ID) patients with chronic heart failure (CHF) has shown great promise according to the findings of recent studies in improvement of symptoms and quality of life, New York Heart ...
Lorenzovici László   +4 more
doaj   +1 more source

The Impact of Budget Reforms on the Quality of Budget Management in Nigeria [PDF]

open access: yesJournal of Accounting and Auditing: Research and Practice, 2014
Budget management reforms were the major areas of the Nigerian public service reforms undertaken from the inception of civilian administration in 1999. The major objective was to enhance budget discipline among others. This was predicated on the theoretical considerations that improving the process and management of budgeting through reforms would be ...
Ben-Caleb, E., Adeyemi, K.S., Iyoha, F.
openaire   +1 more source

Determinants of orphan drug health technology assessment in South Korea: an empirical analysis

open access: yesFrontiers in Pharmacology
BackgroundOrphan drug pricing in South Korea, including its workings and determinants, is a complicated aspect of the country’s healthcare system. Therefore, this study identified the factors associated with the pricing of orphan drugs in South Korea ...
Se Hee Lee   +3 more
doaj   +1 more source

Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay

open access: yesHuman Vaccines & Immunotherapeutics, 2022
This study aimed to investigate the public health and economic benefit of using a quadrivalent influenza vaccine (QIV) instead of a trivalent influenza vaccine (TIV) in past seasons in Paraguay.
Antonio Arbo   +8 more
doaj   +1 more source

Transversal Budget Impact Analysis

open access: yes, 2023
1 INTRODUCTION 11 -- 1.1 CONTEXT 11 -- 1.2 AIM OF THE STUDY 13 -- 1.2.1 Research questions .13 -- 1.3 METHODS 14 -- 1.3.1 Two case studies 14 -- 1.3.2 Data sources analyzed 14 -- 1.3.3 Methods for the data analysis .15 -- 1.4 REPORT OUTLINE .17 -- 2 BACKGROUND 17 -- 2.1 THE GLOBAL AND PARTIAL BUDGETS OF THE FEDERAL RIZIV-INAMI HEALTH INSURANCE BUDGET ...
Camberlin, Cécile   +2 more
openaire   +3 more sources

Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Most influenza vaccines in Mexico are trivalent, containing two influenza A strains and a single B strain. Quadrivalent influenza vaccines (QIVs) extend protection by including an additional B strain to cover both co-circulating B lineages.
Guillermo M. Ruiz-Palacios   +9 more
doaj   +1 more source

The budget impact of oral nutritional supplements for disease related malnutrition in elderly in the community setting

open access: yesFrontiers in Pharmacology, 2012
A health economic analysis was performed to assess the economic impact on the national health care budget of using Oral Nutritional Supplements (ONS), being a food for special medical purposes (FSMP) also known as medical nutrition, for the treatment of ...
Karen eFreyer   +2 more
doaj   +1 more source

Valorising and creating access to innovative medicines in the European Union

open access: yesFrontiers in Pharmacology, 2011
This Perspective describes (a) the current situation, (b) challenges and initiatives, (c) and formulates recommendations to valorize and create access to innovative medicines in the EU. We are currently still far away from optimal assessment of value for
Lieven eAnnemans   +3 more
doaj   +1 more source

Cost-effectiveness study of treatment with biologic disease-modifying antirheumatic drugs in adult patients with active ankylosing spondylitis

open access: yesСовременная ревматология, 2021
Objective: to conduct a cost-effectiveness study of major biologic disease-modifying antirheumatic drugs (bDMARDs) used for the treatment of ankylosing spondylitis (AS) in Russian health care system with the focus on the new effective drug netakimab (NTK)
R. O. Dreval
doaj   +1 more source

Home - About - Disclaimer - Privacy